{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibugxfdwlwllq6u4a63bbt2hftr4ofgx4qyrog2lgzilvpxp3vjry",
    "uri": "at://did:plc:kjur4vuovl5cnpgzydsduib4/app.bsky.feed.post/3mk6i37xauqh2"
  },
  "path": "/business-economix/industry-insights/2026/04/23/pharco-expands-ophthalmic-production-capacity-with-5-8mn-line-in-alexandria/",
  "publishedAt": "2026-04-23T14:27:26.000Z",
  "site": "https://meobserver.org",
  "tags": [
    "Industry Insights",
    "Alexandria",
    "Egypt",
    "Egypt’s ophthalmic market",
    "Egypt’s pharmaceutical sector",
    "Egyptian Drug Authority",
    "Pharco Pharmaceuticals"
  ],
  "textContent": "Alexandria — Pharco Pharmaceuticals has inaugurated a new ophthalmic drops production line at its Al Amreya facility, with investments of approximately $5.8 million (EGP 300 million), as part of a broader expansion programme valued at EGP 500 million. The company stated that the new line will produce up to 20 million packs annually, covering nearly […]",
  "title": "Pharco Expands Ophthalmic Production Capacity with $5.8mn Line in Alexandria"
}